Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-2.69	17.64	18.13
Graham Fair Price	7.45	0.64	0.59
PEG	-80.65	0.93	-4.79
Price/Book	13.76	0.75	0.66
Price/Cash Flow	-93.03	12.36	-177.43
Prices/Earnings	-0.43	13.43	13.49
Price/Sales	14.80	6.24	5.43
Price/FCF	-93.03	12.36	-177.43
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-56.58	0.25	-0.57
Operating Margin	33.62	0.15	0.12
ROA	17.53	< 0.005	< 0.005
ROE	0.01	0.01	14.25
ROIC	< 0.005	< 0.005	35.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	< 0.005	2724.86
Dividends QOQ	< 0.005	-0.68	7706.91
EBIT QOQ	0.10	0.34	256.68
EPS QOQ	-0.03	0.14	414.49
FCF QOQ	-1.18	17.56	1388.50
Revenue QOQ	< 0.005	< 0.005	-31.44
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	22.37	0.04	-99.82
Days Sales Outstanding (DSO)	244.59	229.08	-6.34
Inventory Turnover	4.02	2252.80	55905.21
Debt/Capitalization	0.32	0.30	-5.97
Quick Ratio	1.10	1.46	33.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.13	1.14	0.53
Cash	0.03	0.09	218.45
Capex	-0.06	-0.03	48.36
Free Cash Flow	< 0.005	0.07	1541.67
Revenue	0.14	0.14	-0.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.22	1.45	18.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.46	6.22	-16.64
Naive Interpretation	Member

06 - Financial Health · Weak

Rating